Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Amylx Pharmaceuticals Inc (AMLX) – Amylx Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AMLX trades at $15.20, down 5.35% with a bearish technical signal. The company reported negative earnings and cash flow from operations in 2025, but key Phase 3 trial data for avexitide is expected in Q3 2026, potentially positioning 2026 as transformative. Analyst consensus remains strongly bullish with a $25 price target despite current financial challenges.
The investment thesis hinges on successful avexitide trial results driving future revenue, but carries high risk due to sustained losses and cash burn. Near-term volatility is likely pending clinical updates, with the stock offering high-reward potential contingent on positive data readouts in late 2026.
Read full analysis

Key Stats

  • Market Cap
    $1.64B
  • Sector
    Health
  • 3M Drawdown
    -19.77%
  • Enterprise Value
    $1.36B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    6 days
$14.73
52W Low: $4.35
14 May 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.64B, with an enterprise value of $1.36B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.35 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -19.77%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 6 days, indicating typical investor behavior on the platform.

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.


Technical Indicators
|
|
|
Overall Summary
Bearish (15)Neutral (9)Bullish (3)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.64B
  • Sector
    Health
  • 3M Drawdown
    -19.77%
  • Enterprise Value
    $1.36B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    6 days
$14.73
52W Low: $4.35
14 May 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.64B, with an enterprise value of $1.36B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.35 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -19.77%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 6 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!